Table 1.

Standard Mortality Ratios.

	n	Person-years	Observed	Expected	SMR	95% CI	Mean survival time	95% CI
All patients	296	4079	277	263.18	1.05	0.93-1.18	85.7	84.9-86.5
- Male	96	1326	89	98.04	0.91	0.73-1.11	85.0	83.5-86.4
- Female	200	2752	188	165.14	1.14	0.99-1.31	86.0	85.0-87.0
Age at diagnosis
<60	31	678	21	17.16	1.24	0.78-1.84	78.6	78.0-81.3
60-69	91	1626	84	83.14	1.01	0.81-1.25	83.8	82.2-85.4
70-79	123	1394	121	118.39	1.03	0.85-1.22	86.8	85.7-87.9
≥80	51	380	51	50.64	1.00	0.76-1.31	90.7	89.5-91.8
Men
2 years		185	9	8.29	1.09	0.53-1.99
5 years		436	17	21.03	0.81	0.49-1.27
10 years		788	36	43.67	0.82	0.59-1.13
25 years		1272	83	88.57	0.94	0.75-1.16
Women
2 years		392	11	12.76	0.86	0.45-1.50
5 years		934	32	35.80	0.89	0.62-1.25
10 years		1678	68	74.03	0.92	0.72-1.16
25 years		2687	172	156.21	1.10	0.95-1.28

“Years”: refer to calculated survival time from date of diagnosis; “Observed”: number of deaths in the PMR cohort; “Expected”: number of expected deaths in age-matched, sex-matched, and year-matched background Norwegian Population.